Top Markets
Coin of the day
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Kedudukan dalam Saham #42677
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Harga Saham
$0.00001
Disegerakkan terakhir: 2026-07-30
Modal Pasaran
$426.00
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-90.00%
Negara
US
Perdagangan Kaleido Biosciences, Inc. (KLDO)

Kategori

Sejarah harga saham bagi Kaleido Biosciences, Inc. (KLDO)
Harga penutupan tertinggi: $0.00 pada 2026-07-01

Harga penutupan terendah: $14.23 pada 2019-02-01
Sejarah harga saham Kaleido Biosciences, Inc. dari 2019 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -6.44%
KR